{"id":26654,"date":"2025-02-13T22:17:50","date_gmt":"2025-02-13T14:17:50","guid":{"rendered":"https:\/\/flcube.com\/?p=26654"},"modified":"2025-02-13T22:17:52","modified_gmt":"2025-02-13T14:17:52","slug":"anhui-anke-to-invest-in-visen-pharmas-hong-kong-ipo-as-cornerstone-investor","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=26654","title":{"rendered":"Anhui Anke to Invest in Visen Pharma’s Hong Kong IPO as Cornerstone Investor"},"content":{"rendered":"\n

China – based Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009<\/a>) has announced its plan to subscribe to shares of Visen Pharmaceuticals via its initial public offering (IPO) on the Hong Kong Stock Exchange. Anhui Anke will invest up to USD31 million as a cornerstone investor.<\/p>\n\n\n\n

About Visen Pharmaceuticals<\/strong>
Visen Pharmaceuticals is a China – based joint venture between Denmark – headquartered Ascendis Pharma and Chinese healthcare – focused investment firm Vivo Capital. It is a late – stage biopharmaceutical company with products nearing commercialization.<\/p>\n\n\n\n

Product Pipeline<\/strong>
Visen Pharmaceuticals focuses on providing treatment options for specific endocrine disorders in China, including Hong Kong, Macau, and Taiwan. Its core product is TransCon hGH (lonapegsomatropin – tcgd), a weekly long – acting growth hormone replacement therapy. The company is also developing navepegritide, a long – acting C – type natriuretic peptide (CNP) prodrug for the treatment of cartilage dysplasia, and palopegteriparatide, a daily parathyroid hormone replacement therapy for chronic hypoparathyroidism.-Fineline Info & Tech<\/a><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

China – based Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009) has announced its plan…<\/p>\n","protected":false},"author":1,"featured_media":26655,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[482,20,72,997,393],"class_list":["post-26654","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-anke-biotechnology","tag-finance","tag-ipo","tag-she-300009","tag-visen-pharmaceuticals"],"yoast_head":"\nAnhui Anke to Invest in Visen Pharma's Hong Kong IPO as Cornerstone Investor - Insight, China's Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China - based Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009) has announced its plan to subscribe to shares of Visen Pharmaceuticals via its initial public offering (IPO) on the Hong Kong Stock Exchange. Anhui Anke will invest up to USD31 million as a cornerstone investor.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=26654\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anhui Anke to Invest in Visen Pharma's Hong Kong IPO as Cornerstone Investor\" \/>\n<meta property=\"og:description\" content=\"China - based Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009) has announced its plan to subscribe to shares of Visen Pharmaceuticals via its initial public offering (IPO) on the Hong Kong Stock Exchange. Anhui Anke will invest up to USD31 million as a cornerstone investor.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=26654\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China's Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-13T14:17:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-13T14:17:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/1305-1-png.avif\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=26654#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=26654\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Anhui Anke to Invest in Visen Pharma’s Hong Kong IPO as Cornerstone Investor\",\"datePublished\":\"2025-02-13T14:17:50+00:00\",\"dateModified\":\"2025-02-13T14:17:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=26654\"},\"wordCount\":175,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=26654#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/1305-1-png.avif\",\"keywords\":[\"Anke Biotechnology\",\"Finance\",\"IPO\",\"SHE: 300009\",\"Visen Pharmaceuticals\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=26654#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=26654\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=26654\",\"name\":\"Anhui Anke to Invest in Visen Pharma's Hong Kong IPO as Cornerstone Investor - Insight, China's Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=26654#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=26654#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/1305-1-png.avif\",\"datePublished\":\"2025-02-13T14:17:50+00:00\",\"dateModified\":\"2025-02-13T14:17:52+00:00\",\"description\":\"China - based Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009) has announced its plan to subscribe to shares of Visen Pharmaceuticals via its initial public offering (IPO) on the Hong Kong Stock Exchange. Anhui Anke will invest up to USD31 million as a cornerstone investor.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=26654#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=26654\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=26654#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/1305-1-png.avif\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/02\\\/1305-1-png.avif\",\"width\":1080,\"height\":608,\"caption\":\"Anhui Anke to Invest in Visen Pharma's Hong Kong IPO as Cornerstone Investor\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=26654#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anhui Anke to Invest in Visen Pharma’s Hong Kong IPO as Cornerstone Investor\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Anhui Anke to Invest in Visen Pharma's Hong Kong IPO as Cornerstone Investor - Insight, China's Pharmaceutical Industry","description":"China - based Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009) has announced its plan to subscribe to shares of Visen Pharmaceuticals via its initial public offering (IPO) on the Hong Kong Stock Exchange. Anhui Anke will invest up to USD31 million as a cornerstone investor.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=26654","og_locale":"en_US","og_type":"article","og_title":"Anhui Anke to Invest in Visen Pharma's Hong Kong IPO as Cornerstone Investor","og_description":"China - based Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009) has announced its plan to subscribe to shares of Visen Pharmaceuticals via its initial public offering (IPO) on the Hong Kong Stock Exchange. Anhui Anke will invest up to USD31 million as a cornerstone investor.","og_url":"https:\/\/flcube.com\/?p=26654","og_site_name":"Insight, China's Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-02-13T14:17:50+00:00","article_modified_time":"2025-02-13T14:17:52+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/1305-1-png.avif","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=26654#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=26654"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Anhui Anke to Invest in Visen Pharma’s Hong Kong IPO as Cornerstone Investor","datePublished":"2025-02-13T14:17:50+00:00","dateModified":"2025-02-13T14:17:52+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=26654"},"wordCount":175,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=26654#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/1305-1-png.avif","keywords":["Anke Biotechnology","Finance","IPO","SHE: 300009","Visen Pharmaceuticals"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=26654#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=26654","url":"https:\/\/flcube.com\/?p=26654","name":"Anhui Anke to Invest in Visen Pharma's Hong Kong IPO as Cornerstone Investor - Insight, China's Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=26654#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=26654#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/1305-1-png.avif","datePublished":"2025-02-13T14:17:50+00:00","dateModified":"2025-02-13T14:17:52+00:00","description":"China - based Anhui Anke Biotechnology (Group) Co., Ltd (SHE: 300009) has announced its plan to subscribe to shares of Visen Pharmaceuticals via its initial public offering (IPO) on the Hong Kong Stock Exchange. Anhui Anke will invest up to USD31 million as a cornerstone investor.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=26654#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=26654"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=26654#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/1305-1-png.avif","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/1305-1-png.avif","width":1080,"height":608,"caption":"Anhui Anke to Invest in Visen Pharma's Hong Kong IPO as Cornerstone Investor"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=26654#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Anhui Anke to Invest in Visen Pharma’s Hong Kong IPO as Cornerstone Investor"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/02\/1305-1-png.avif","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/26654","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26654"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/26654\/revisions"}],"predecessor-version":[{"id":26656,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/26654\/revisions\/26656"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/26655"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26654"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=26654"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=26654"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}